Zofran Birth Defect Lawsuits in South Carolina
Zofran (ondansetron) is a prescription nausea medication manufactured by GlaxoSmithKline that was prescribed by some doctors as a treatment for severe morning sickness. Zofran is under scrutiny for increasing risk of serious birth defects including cleft lip, cleft palate, mouth deformities and congenital heart defects.
The drug was approved by the U.S. Food and Drug Administration (FDA) as a medication for patients suffering nausea and vomiting caused by chemotherapy treatments, radiation therapy and surgery. It never received FDA approval for the treatment of morning sickness during pregnancy.